Company Overview of Vironova AB (publ.)
Vironova AB (publ) provides a range of products and services used in the development of particles for vaccines, drug delivery, and gene therapy, as well as viral safety testing and material quality control. The company specializes in electron microscopy, virology, mathematics, and image analysis. It offers MiniTEM, a low-voltage transmission electron microscope system; and Vironova Analyzer software for the analysis of transmission electron microscopy images of nanoparticles, such as VLP’s, liposomes, viruses, and inorganic materials. The company was formerly known as Intelligent Virus Imaging. Vironova AB (publ) was founded in 2005 and is based in Stockholm, Sweden.
Stockholm, 113 30
Founded in 2005
Key Executives for Vironova AB (publ.)
Similar Private Companies By Industry
|Abera Bioscience AB||Europe|
|Adenovir Pharma AB||Europe|
|Affibody Medical AB (publ)||Europe|
|Akinion Pharmaceuticals AB||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Vironova AB (publ.), please visit www.vironova.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.